The outcomes of aflibercept therapy in patients with age-related macular degeneration resistant to bevacizumab or ranibizumab

PURPOSE: This study was designed to assess the functional and anatomic outcomes of intravitreal aflibercept injection in patients with wet age-related macular degeneration (AMD) refractory to intravitreal bevacizumab or ranibizumab therapy. METHODS: This retrospective study included 43 eyes of 43 pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Unsal, Erkan, Cubuk, Mehmet Ozgur
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6276726/
https://www.ncbi.nlm.nih.gov/pubmed/30555967
http://dx.doi.org/10.1016/j.joco.2018.07.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6276726/
https://www.ncbi.nlm.nih.gov/pubmed/30555967
http://dx.doi.org/10.1016/j.joco.2018.07.002

Ejemplares similares